In the biopharma industry, there currently is a need to increase production capacity to meet the analytical demands of process development and characterization, which investigate multiple parameters. The requirement for shorter turnaround times, smaller sample volumes, and increased sample numbers is no easy request to fill. Yet many investigators are turning their focus toward high throughput automation, which they believe is paramount to achieving these goals. In this GEN webinar, we will hear about some of the latest advances in high-throughput analytics, with particular attention on the High-Throughput Impurity Detection platform for automated impurity quantitation from Lonza. Additionally, we will hear about some of the unique automation challenges that face biomanufacturers, as well as some novel chemistry and vendor selection methodologies that have been designed to save researchers valuable time and money.
A live Q&A session will follow the presentations, offering you a chance to pose questions to our expert panelist.